Asia-Pacific Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others



Summary



GlobalData’s new report, “Asia-Pacific Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the Asia-Pacific Neurology Devices market – Australia, China, India and Japan. The report provides value (USD million) data for all the market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Countries covered include Australia, China, India and Japan.
- Market size and company share data for Neurology Devices market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Neurology Devices market..
- Key players covered include Medtronic, Inc., Terumo Corporation, DePuy, Inc., Boston Scientific Corporation, Nihon Kohden Corporation, Micrus Endovascular Corporation and others.



Reasons to buy


- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Asia-Pacific Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table Of Contents

Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What is This Report About? 12
3 Neurology Devices in Asia-Pacific 13
3.1 Neurology Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 13
3.2 Neurology Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018 14
3.3 Neurology Devices, Asia-Pacific, Company share (2010-2011) 21
4 Neurology Devices In Japan 23
4.1 Neurology Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 23
4.2 Neurology Devices, Japan, Distribution Share (2010-2011) 29
4.2.1 CSF Management, Japan, Distribution Share (2010-2011) 29
4.2.2 Interventional Neurology, Japan, Distribution Share (2010-2011) 29
4.2.3 Neurological Diagnostic Equipment, Japan, Distribution Share (2010-2011) 30
4.2.4 Neurostimulation Devices, Japan, Distribution Share (2010-2011) 30
4.2.5 Neurosurgical Products, Japan, Distribution Share (2010-2011) 31
4.2.6 Radiosurgery, Japan, Distribution Share (2010-2011) 31
4.3 Neurology Devices, Japan, Company Share (2010-2011) 32
4.3.1 Neurology Devices, Japan, Company Share (2010-2011) 32
4.3.2 CSF Management, Japan, Company Share (2010-2011) 34
4.3.3 Interventional Neurology, Japan, Company Share (2010-2011) 36
4.3.4 Neurological Diagnostic Equipment, Japan, Company Share (2010-2011) 38
4.3.5 Neurostimulation Devices, Japan, Company Share (2010-2011) 39
4.3.6 Neurosurgical Products, Japan, Company Share (2010-2011) 40
4.3.7 Radiosurgery, Japan, Company Share (2010-2011) 42
5 Neurology Devices In Australia 43
5.1 Neurology Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 43
5.2 Neurology Devices, Australia, Distribution Share (2010-2011) 49
5.2.1 CSF Management, Australia, Distribution Share (2010-2011) 49
5.2.2 Interventional Neurology, Australia, Distribution Share (2010-2011) 49
5.2.3 Neurological Diagnostic Equipment, Australia, Distribution Share (2010-2011) 50
5.2.4 Neurostimulation Devices, Australia, Distribution Share (2010-2011) 50
5.2.5 Neurosurgical Products, Australia, Distribution Share (2010-2011) 51
5.3 Neurology Devices, Australia, Company Share (2010-2011) 52
5.3.1 Neurology Devices, Australia, Company Share (2010-2011) 52
5.3.2 CSF Management, Australia, Company Share (2010-2011) 54
5.3.3 Interventional Neurology, Australia, Company Share (2010-2011) 56
5.3.4 Neurological Diagnostic Equipment, Australia, Company Share (2010-2011) 58
5.3.5 Neurostimulation Devices, Australia, Company Share (2010-2011) 60
5.3.6 Neurosurgical Products, Australia, Company Share (2010-2011) 61
6 Neurology Devices In China 62
6.1 Neurology Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 62
6.2 Neurology Devices, China, Distribution Share (2010-2011) 68
6.2.1 CSF Management, China, Distribution Share (2010-2011) 68
6.2.2 Interventional Neurology, China, Distribution Share (2010-2011) 68
6.2.3 Neurological Diagnostic Equipment, China, Distribution Share (2010-2011) 69
6.2.4 Neurostimulation Devices, China, Distribution Share (2010-2011) 69
6.2.5 Neurosurgical Products, China, Distribution Share (2010-2011) 70
6.2.6 Radiosurgery, China, Distribution Share (2010-2011) 70
6.3 Neurology Devices, China, Company Share (2010-2011) 71
6.3.1 Neurology Devices, China, Company Share (2010-2011) 71
6.3.2 CSF Management, China, Company Share (2010-2011) 73
6.3.3 Interventional Neurology, China, Company Share (2010-2011) 75
6.3.4 Neurological Diagnostic Equipment, China, Company Share (2010-2011) 77
6.3.5 Neurostimulation Devices, China, Company Share (2010-2011) 79
6.3.6 Neurosurgical Products, China, Company Share (2010-2011) 80
6.3.7 Radiosurgery, China, Company Share (2010-2011) 81
7 Neurology Devices In India 82
7.1 Neurology Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 82
7.2 Neurology Devices, India, Distribution Share (2010-2011) 88
7.2.1 CSF Management, India, Distribution Share (2010-2011) 88
7.2.2 Interventional Neurology, India, Distribution Share (2010-2011) 88
7.2.3 Neurological Diagnostic Equipment, India, Distribution Share (2010-2011) 89
7.2.4 Neurostimulation Devices, India, Distribution Share (2010-2011) 89
7.2.5 Neurosurgical Products, India, Distribution Share (2010-2011) 90
7.2.6 Radiosurgery, India, Distribution Share (2010-2011) 90
7.3 Neurology Devices, India, Company Share (2010-2011) 91
7.3.1 Neurology Devices, India, Company Share (2010-2011) 91
7.3.2 CSF Management, India, Company Share (2010-2011) 93
7.3.3 Interventional Neurology, India, Company Share (2010-2011) 95
7.3.4 Neurological Diagnostic Equipment, India, Company Share (2010-2011) 97
7.3.5 Neurostimulation Devices, India, Company Share (2010-2011) 98
7.3.6 Neurosurgical Products, India, Company Share (2010-2011) 99
7.3.7 Radiosurgery, India, Company Share (2010-2011) 101
8 Overview of Key Companies in Asia-Pacific Neurology Devices Market 102
8.1 Medtronic, Inc. 102
8.1.1 Company Overview 102
8.1.2 Share in the Asia-Pacific Neurology Devices Market 102
8.2 DePuy, Inc. 103
8.2.1 Company Overview 103
8.2.2 Share in the Asia-Pacific Neurology Devices Market 103
8.3 Terumo Corporation 104
8.3.1 Company Overview 104
8.3.2 Share in the Asia-Pacific Neurology Devices Market 104
8.4 Stryker Corporation 105
8.4.1 Company Overview 105
8.4.2 Share in the Asia-Pacific Neurology Devices Market 105
8.5 Nihon Kohden Corporation 106
8.5.1 Company Overview 106
8.5.2 Share in the Asia-Pacific Neurology Devices Market 106
8.6 Covidien plc 107
8.6.1 Company Overview 107
8.6.2 Share in the Asia-Pacific Neurology Devices Market 107
8.7 St. Jude Medical, Inc. 108
8.7.1 Company Overview 108
8.8 Accuray Incorporated 108
8.8.1 Company Overview 108
8.9 B. Braun Melsungen AG 109
8.9.1 Company Overview 109
8.10 CareFusion Corporation 109
8.10.1 Company Overview 109
8.11 Olympus Corporation 110
8.11.1 Company Overview 110
8.12 Elekta AB 110
8.12.1 Company Overview 110
8.13 W. L. Gore and Associates, Inc. 110
8.13.1 Company Overview 110
8.14 Mizuho Ikakogyo Co., Ltd. 111
8.14.1 Company Overview 111
8.15 Integra LifeSciences Holdings Corporation 111
8.15.1 Company Overview 111
8.16 KARL STORZ GmbH and Co. KG 111
8.16.1 Company Overview 111
8.17 Boston Scientific Corporation 112
8.17.1 Company Overview 112
8.18 Cyberonics, Inc. 112
8.18.1 Company Overview 112
8.19 Natus Medical Incorporated 113
8.19.1 Company Overview 113
8.20 Christoph Miethke GmbH and Co. KG 113
8.20.1 Company Overview 113
8.21 Cadwell Laboratories, Inc. 113
8.21.1 Company Overview 113
8.22 Sophysa S.A. 114
8.22.1 Company Overview 114
8.23 Compumedics Limited 114
8.23.1 Company Overview 114
8.24 G. Surgiwear Limited 114
8.24.1 Company Overview 114
8.25 Micromed S.p.A 115
8.25.1 Company Overview 115
9 Neurology Devices Market Pipeline Products 116
10 Recent Developments 121
10.1 Strategy And Business Planning 121
10.1.1 Jan 31, 2012: Boston Scientific Announces New Asia-Pacific Organization 121
10.1.2 Dec 05, 2011: Integra LifeSciences Establishes First Office In Shanghai, China 122
10.1.3 Nov 02, 2011: Accellent Opens New Manufacturing Plant In Penang, Malaysia 122
10.1.4 Jul 25, 2011: DePuy Opens Institute For Advanced Education And Research In Orthopedic And Neurological Care In India 123
10.2 Government and Public Interest 124
10.2.1 Jun 24, 2011: Accuray Hosts Korean Embassy's Minister for Economic Affairs At Event To Support US-Korea Free Trade Agreement 124
11 Appendix 125
11.1 Definitions of Markets Covered in the Report 126
11.1.1 Neurology Devices 126
11.2 Research Methodology 127
11.3 Secondary Research 127
11.4 Primary Research 128
11.5 Models 128
11.6 Forecasts 129
11.7 Expert Panels 129
11.8 GlobalData Consulting 129
11.9 Currency Conversion 130
11.10 Contact Us 130
11.11 Disclaimer 130
List of Tables

1.1 List of Tables
Table 1: Neurology Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 13
Table 2: Neurology Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018 15
Table 3: Neurology Devices, Asia-Pacific, Cross-Category Analysis, 2004-2018 16
Table 4: Neurology Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011 18
Table 5: Neurology Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 20
Table 6: Neurology Devices, Asia-Pacific, Company share by Revenue ($m), USD Constant, 2010-2011 22
Table 7: Neurology Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 24
Table 8: Neurology Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 26
Table 9: Neurology Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 28
Table 10: CSF Management, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 29
Table 11: Interventional Neurology, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 29
Table 12: Neurological Diagnostic Equipment, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 30
Table 13: Neurostimulation Devices, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 30
Table 14: Neurosurgical Products, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 31
Table 15: Radiosurgery, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 31
Table 16: Neurology Devices, Japan, Company Share, USD Constant, (2010-2011) 33
Table 17: CSF Management, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 35
Table 18: Interventional Neurology, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 37
Table 19: Neurological Diagnostic Equipment, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 38
Table 20: Neurostimulation Devices, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 39
Table 21: Neurosurgical Products, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 41
Table 22: Radiosurgery, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 42
Table 23: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 44
Table 24: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 46
Table 25: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 48
Table 26: CSF Management, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 49
Table 27: Interventional Neurology, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 49
Table 28: Neurological Diagnostic Equipment, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 50
Table 29: Neurostimulation Devices, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 50
Table 30: Neurosurgical Products, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 51
Table 31: Neurology Devices, Australia, Company Share, USD Constant, (2010-2011) 53
Table 32: CSF Management, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 55
Table 33: Interventional Neurology, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 57
Table 34: Neurological Diagnostic Equipment, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 59
Table 35: Neurostimulation Devices, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 60
Table 36: Neurosurgical Products, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 61
Table 37: Neurology Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 63
Table 38: Neurology Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 65
Table 39: Neurology Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 67
Table 40: CSF Management, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 68
Table 41: Interventional Neurology, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 68
Table 42: Neurological Diagnostic Equipment, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 69
Table 43: Neurostimulation Devices, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 69
Table 44: Neurosurgical Products, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 70
Table 45: Radiosurgery, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 70
Table 46: Neurology Devices, China, Company Share by Revenue ($m), USD Constant, 2010-2011 72
Table 47: CSF Management, China, Company Share by Revenue ($m), USD Constant, 2010-2011 74
Table 48: Interventional Neurology, China, Company Share by Revenue ($m), USD Constant, 2010-2011 76
Table 49: Neurological Diagnostic Equipment, China, Company Share by Revenue ($m), USD Constant, 2010-2011 78
Table 50: Neurostimulation Devices, China, Company Share by Revenue ($m), USD Constant, 2010-2011 79
Table 51: Neurosurgical Products, China, Company Share by Revenue ($m), USD Constant, 2010-2011 80
Table 52: Radiosurgery, China, Company Share by Revenue ($m), USD Constant, 2010-2011 81
Table 53: Neurology Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 83
Table 54: Neurology Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 85
Table 55: Neurology Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 87
Table 56: CSF Management, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 88
Table 57: Interventional Neurology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 88
Table 58: Neurological Diagnostic Equipment, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 89
Table 59: Neurostimulation Devices, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 89
Table 60: Neurosurgical Products, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 90
Table 61: Radiosurgery, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 90
Table 62: Neurology Devices, India, Company Share by Revenue ($m), USD Constant, 2010-2011 92
Table 63: CSF Management, India, Company Share by Revenue ($m), USD Constant, 2010-2011 94
Table 64: Interventional Neurology, India, Company Share by Revenue ($m), USD Constant, 2010-2011 96
Table 65: Neurological Diagnostic Equipment, India, Company Share by Revenue ($m), USD Constant, 2010-2011 97
Table 66: Neurostimulation Devices, India, Company Share by Revenue ($m), USD Constant, 2010-2011 98
Table 67: Neurosurgical Products, India, Company Share by Revenue ($m), USD Constant, 2010-2011 100
Table 68: Radiosurgery, India, Company Share by Revenue ($m), USD Constant, 2010-2011 101
Table 69: Neurology Devices Market Pipeline Products 116
List of Figures

1.2 List of Figures
Figure 1: Neurology Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 13
Figure 2: Neurology Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018 14
Figure 3: Neurology Devices, Asia-Pacific, Cross-Category Analysis, 2004-2018 16
Figure 4: Neurology Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17
Figure 5: Neurology Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19
Figure 6: Neurology Devices, Asia-Pacific, Company share (%), 2011 21
Figure 7: Neurology Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 23
Figure 8: Neurology Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25
Figure 9: Neurology Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27
Figure 10: Neurology Devices, Japan, Company Share (%), 2011 32
Figure 11: CSF Management, Japan, Company Share (%), 2011 34
Figure 12: Interventional Neurology, Japan, Company Share (%), 2011 36
Figure 13: Neurological Diagnostic Equipment, Japan, Company Share (%), 2011 38
Figure 14: Neurostimulation Devices, Japan, Company Share (%), 2011 39
Figure 15: Neurosurgical Products, Japan, Company Share (%), 2011 40
Figure 16: Radiosurgery, Japan, Company Share (%), 2011 42
Figure 17: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 43
Figure 18: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 45
Figure 19: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 47
Figure 20: Neurology Devices, Australia, Company Share (%), 2011 52
Figure 21: CSF Management, Australia, Company Share (%), 2011 54
Figure 22: Interventional Neurology, Australia, Company Share (%), 2011 56
Figure 23: Neurological Diagnostic Equipment, Australia, Company Share (%), 2011 58
Figure 24: Neurostimulation Devices, Australia, Company Share (%), 2011 60
Figure 25: Neurosurgical Products, Australia, Company Share (%), 2011 61
Figure 26: Neurology Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 62
Figure 27: Neurology Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 64
Figure 28: Neurology Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 66
Figure 29: Neurology Devices, China, Company Share (%), 2011 71
Figure 30: CSF Management, China, Company Share (%), 2011 73
Figure 31: Interventional Neurology, China, Company Share (%), 2011 75
Figure 32: Neurological Diagnostic Equipment, China, Company Share (%), 2011 77
Figure 33: Neurostimulation Devices, China, Company Share (%), 2011 79
Figure 34: Neurosurgical Products, China, Company Share (%), 2011 80
Figure 35: Neurology Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 82
Figure 36: Neurology Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 84
Figure 37: Neurology Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 86
Figure 38: Neurology Devices, India, Company Share (%), 2011 91
Figure 39: CSF Management, India, Company Share (%), 2011 93
Figure 40: Interventional Neurology, India, Company Share (%), 2011 95
Figure 41: Neurological Diagnostic Equipment, India, Company Share (%), 2011 97
Figure 42: Neurostimulation Devices, India, Company Share (%), 2011 98
Figure 43: Neurosurgical Products, India, Company Share (%), 2011 99
Figure 44: Medtronic, Inc., Company Share (%), Asia-Pacific Neurology Devices Market, 2011 102
Figure 45: DePuy, Inc., Company Share (%), Asia-Pacific Neurology Devices Market, 2011 103
Figure 46: Terumo Corporation, Company Share (%), Asia-Pacific Neurology Devices Market, 2011 104
Figure 47: Stryker Corporation, Company Share (%), Asia-Pacific Neurology Devices Market, 2011 105
Figure 48: Nihon Kohden Corporation, Company Share (%), Asia-Pacific Neurology Devices Market, 2011 106
Figure 49: Covidien plc, Company Share (%), Asia-Pacific Neurology Devices Market, 2011 107
Companies Mentioned

Medtronic, Inc.
DePuy, Inc.
Terumo Corporation
Stryker Corporation
Nihon Kohden Corporation
Covidien plc
St. Jude Medical, Inc.
Accuray Incorporated
B. Braun Melsungen AG
CareFusion Corporation
Olympus Corporation
Elekta AB
W. L. Gore and Associates, In

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Medical Specialty Bags Market

Global Medical Specialty Bags Market

  • $ 4 950
  • Industry report
  • May 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Medical Specialty Bags in US$ Thousands by the following Product Segments: Bile Collection Bags, Blood Bags, Breathing Bags, Cadaver Bags, Enema Bags, Enteral ...

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products & Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products & Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital ...

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products...) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products...) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.